Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 3/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.31 |
| ▸ | WNT3A | P56704 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5707632 | 1.00 | P2RX7 (0.32) | P2RX7SLC6A2SLC6A4SLC6A3NPC1 | |
| SCHEMBL4982728 | 1.00 | P2RX7 (0.32) | P2RX7SLC6A2SLC6A4SLC6A3NPC1 | |
| SCHEMBL4750928 | 0.90 | SLC6A2 (0.31) | P2RX7SLC6A2SLC6A4SLC6A3HTT | |
| SCHEMBL3395341 | 0.85 | HTT (0.33) | P2RX7SLC6A2SLC6A4SLC6A3NPC1 | |
| SCHEMBL6842407 | 0.84 | SLC6A2 (0.33) | P2RX7SLC6A2SLC6A4SLC6A3NPC1 | |
| SCHEMBL2907033 | 0.84 | SLC6A2 (0.33) | P2RX7SLC6A2SLC6A4SLC6A3NPC1 | |
| SCHEMBL8960840 | 0.84 | SLC6A2 (0.33) | P2RX7SLC6A2SLC6A4SLC6A3NPC1 | |
| SCHEMBL5707587 | 0.84 | SLC6A2 (0.33) | P2RX7SLC6A2SLC6A4SLC6A3NPC1 | |
| SCHEMBL6844452 | 0.81 | ALDH1A1 (0.39) | NPC1RAB9AHTTALDH1A1KMT2A | |
| SCHEMBL6843109 | 0.78 | AR (0.44) | NPC1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060229275-A1 | Production method of 2-deoxy-L-ribofuranosyl chloride compound | AJINOMOTO CO. INC (JP) | 2006-10-12 | — | — | US | disclosed |
| EP-1705181-A2 | Production method of 2-deoxy-L-ribofuranosyl chloride compound | AJINOMOTO CO., INC. (JP) | 2006-09-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060229275-A1 | Production method of 2-deoxy-L-ribofuranosyl chloride compound | DCTD, DERA, HDHD5 | P2RX7 2082/4885SLC6A2 2300/4885SLC6A4 1792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.